Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S. SURGICAL'S ACCELERATED MOVE TO JUST-IN-TIME DISTRIBUTION

This article was originally published in The Gray Sheet

Executive Summary

U.S. SURGICAL'S ACCELERATED MOVE TO JUST-IN-TIME DISTRIBUTION includes a "large number of JIT accounts added during the first quarter" of fiscal 1993 ended March 31, the firm noted in an April 7 press release. U.S. Surgical Chairman Leon Hirsch explained that "for approximately one year, the company has been experimenting with a just-in-time distributor program. As a result of the positive reaction of its test hospitals, the company accelerated significantly its JIT program during the latter part of the first quarter." The company, which issued the statement "in response to growing investor speculation," said that the change in distribution patterns would depress revenue in the second and third quarters. The JIT accounts "will result in significantly reduced sales for the second and third quarter of this year as hospitals use up their inventories. The company expects second quarter sales to be flat or slightly down from the prior year's comparable quarter, followed by an improving trend in the third quarter and a strong fourth quarter," Hirsch said. The company said that despite the revenue shortfall, it "will continue its aggressive surgical training programs and will expand further its R&D expenditures to ensure future growth. These continuing expenses will result in sharply down second quarter earnings." However, the company predicted "sequential improvement in the third quarter and strong improvement in the fourth quarter." Earnings for the year will be off compared to 1992, the firm said. U.S. Surgical reported earnings of $34.8 mil. on sales of $304.8 mil. for second quarter fiscal 1992. The company netted $36.5 mil. from $293.3 mil. in revenues for the third quarter of that year. While acknowledging that the "short term sales and profit impact of this program will be negative, we believe long term JIT servicing will put us in a more competitive position in dealing with our customers." U.S. Surgical maintained that hospitals have found that the distribution system helps "reduce inventory levels and the costs connected with handling large inventories." In addition, the firm said that it finds the distribution system beneficial because distributor handling of hospital inventory frees up more time for the U.S. Surgical technical sales force's support and teaching activities. Hospitals that participate in the Just-In-Time program select a distributor that will supply them with all of their U.S. Surgical inventory. After a participating hospital has reduced its inventory, its distributor delivers U.S. Surgical supplies daily. The distributor also orders sufficient supplies each month to replenish inventory used by the hospital during the previous month.

You may also be interested in...



QUOTED. 20 February 2020. Steven Raman.

Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.

Novartis Logs Into India With Digital Innovation Hub

Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.

Rx List Price Inflation Penalty Endorsed By US HHS Secretary

Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.

UsernamePublicRestriction

Register

MT000484

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel